验证用于临床试验的代谢相关性脂肪性肝炎全切片图像管理系统。

IF 3.4 2区 医学 Q1 PATHOLOGY
Hanna Pulaski, Shraddha S Mehta, Laryssa C Manigat, Stephanie Kaufman, Hypatia Hou, ILKe Nalbantoglu, Xuchen Zhang, Emily Curl, Ross Taliano, Tae Hun Kim, Michael Torbenson, Jonathan N Glickman, Murray B Resnick, Neel Patel, Cristin E Taylor, Pierre Bedossa, Michael C Montalto, Andrew H Beck, Katy E Wack
{"title":"验证用于临床试验的代谢相关性脂肪性肝炎全切片图像管理系统。","authors":"Hanna Pulaski,&nbsp;Shraddha S Mehta,&nbsp;Laryssa C Manigat,&nbsp;Stephanie Kaufman,&nbsp;Hypatia Hou,&nbsp;ILKe Nalbantoglu,&nbsp;Xuchen Zhang,&nbsp;Emily Curl,&nbsp;Ross Taliano,&nbsp;Tae Hun Kim,&nbsp;Michael Torbenson,&nbsp;Jonathan N Glickman,&nbsp;Murray B Resnick,&nbsp;Neel Patel,&nbsp;Cristin E Taylor,&nbsp;Pierre Bedossa,&nbsp;Michael C Montalto,&nbsp;Andrew H Beck,&nbsp;Katy E Wack","doi":"10.1002/2056-4538.12395","DOIUrl":null,"url":null,"abstract":"<p>The gold standard for enrollment and endpoint assessment in metabolic dysfunction-associated steatosis clinical trials is histologic assessment of a liver biopsy performed on glass slides. However, obtaining the evaluations from several expert pathologists on glass is challenging, as shipping the slides around the country or around the world is time-consuming and comes with the hazards of slide breakage. This study demonstrated that pathologic assessment of disease activity in steatohepatitis, performed using digital images on the AISight whole slide image management system, yields results that are comparable to those obtained using glass slides. The accuracy of scoring for steatohepatitis (nonalcoholic fatty liver disease activity score ≥4 with ≥1 for each feature and absence of atypical features suggestive of other liver disease) performed on the system was evaluated against scoring conducted on glass slides. Both methods were assessed for overall percent agreement with a consensus “ground truth” score (defined as the median score of a panel of three pathologists’ glass slides). Each case was also read by three different pathologists, once on glass and once digitally with a minimum 2-week washout period between the modalities. It was demonstrated that the average agreement across three pathologists of digital scoring with ground truth was noninferior to the average agreement of glass scoring with ground truth [noninferiority margin: −0.05; difference: −0.001; 95% CI: (−0.027, 0.026); and <i>p</i> &lt; 0.0001]. For each pathologist, there was a similar average agreement of digital and glass reads with glass ground truth (pathologist A, 0.843 and 0.849; pathologist B, 0.633 and 0.605; and pathologist C, 0.755 and 0.780). Here, we demonstrate that the accuracy of digital reads for steatohepatitis using digital images is equivalent to glass reads in the context of a clinical trial for scoring using the Clinical Research Network scoring system.</p>","PeriodicalId":48612,"journal":{"name":"Journal of Pathology Clinical Research","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/2056-4538.12395","citationCount":"0","resultStr":"{\"title\":\"Validation of a whole slide image management system for metabolic-associated steatohepatitis for clinical trials\",\"authors\":\"Hanna Pulaski,&nbsp;Shraddha S Mehta,&nbsp;Laryssa C Manigat,&nbsp;Stephanie Kaufman,&nbsp;Hypatia Hou,&nbsp;ILKe Nalbantoglu,&nbsp;Xuchen Zhang,&nbsp;Emily Curl,&nbsp;Ross Taliano,&nbsp;Tae Hun Kim,&nbsp;Michael Torbenson,&nbsp;Jonathan N Glickman,&nbsp;Murray B Resnick,&nbsp;Neel Patel,&nbsp;Cristin E Taylor,&nbsp;Pierre Bedossa,&nbsp;Michael C Montalto,&nbsp;Andrew H Beck,&nbsp;Katy E Wack\",\"doi\":\"10.1002/2056-4538.12395\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The gold standard for enrollment and endpoint assessment in metabolic dysfunction-associated steatosis clinical trials is histologic assessment of a liver biopsy performed on glass slides. However, obtaining the evaluations from several expert pathologists on glass is challenging, as shipping the slides around the country or around the world is time-consuming and comes with the hazards of slide breakage. This study demonstrated that pathologic assessment of disease activity in steatohepatitis, performed using digital images on the AISight whole slide image management system, yields results that are comparable to those obtained using glass slides. The accuracy of scoring for steatohepatitis (nonalcoholic fatty liver disease activity score ≥4 with ≥1 for each feature and absence of atypical features suggestive of other liver disease) performed on the system was evaluated against scoring conducted on glass slides. Both methods were assessed for overall percent agreement with a consensus “ground truth” score (defined as the median score of a panel of three pathologists’ glass slides). Each case was also read by three different pathologists, once on glass and once digitally with a minimum 2-week washout period between the modalities. It was demonstrated that the average agreement across three pathologists of digital scoring with ground truth was noninferior to the average agreement of glass scoring with ground truth [noninferiority margin: −0.05; difference: −0.001; 95% CI: (−0.027, 0.026); and <i>p</i> &lt; 0.0001]. For each pathologist, there was a similar average agreement of digital and glass reads with glass ground truth (pathologist A, 0.843 and 0.849; pathologist B, 0.633 and 0.605; and pathologist C, 0.755 and 0.780). Here, we demonstrate that the accuracy of digital reads for steatohepatitis using digital images is equivalent to glass reads in the context of a clinical trial for scoring using the Clinical Research Network scoring system.</p>\",\"PeriodicalId\":48612,\"journal\":{\"name\":\"Journal of Pathology Clinical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/2056-4538.12395\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pathology Clinical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/2056-4538.12395\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pathology Clinical Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/2056-4538.12395","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

代谢功能障碍相关脂肪变性临床试验的入组和终点评估金标准是在玻璃切片上对肝活检进行组织学评估。然而,从多位病理专家那里获得玻璃切片的评估结果非常具有挑战性,因为将切片运送到全国各地或世界各地非常耗时,而且还存在切片破损的危险。这项研究表明,使用 AISight 全玻片图像管理系统上的数字图像对脂肪性肝炎的疾病活动性进行病理评估,得出的结果与使用玻璃玻片得出的结果相当。该系统对脂肪性肝炎评分(非酒精性脂肪肝活动度评分≥4,每个特征评分≥1,且无提示其他肝病的不典型特征)的准确性与玻璃切片评分进行了评估。对两种方法与 "基本真实 "评分(定义为三位病理学家玻璃切片小组评分的中位数)的总体百分比一致性进行了评估。每个病例还由三位不同的病理学家进行阅读,一次是玻璃载玻片阅读,一次是数字载玻片阅读,两种方式之间至少有两周的缓冲期。结果表明,三位病理学家的数字评分与地面实况的平均一致性并不比玻璃评分与地面实况的平均一致性差[非劣效差:-0.05;差异:-0.001;95%]:-0.001;95% CI:(-0.027, 0.026);p < 0.0001]。每位病理学家的数字和玻璃读数与玻璃地面实况的平均一致性相似(病理学家 A 为 0.843 和 0.849;病理学家 B 为 0.633 和 0.605;病理学家 C 为 0.755 和 0.780)。在此,我们证明在使用临床研究网络评分系统进行评分的临床试验中,使用数字图像对脂肪性肝炎进行数字读取的准确性等同于玻璃读取。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Validation of a whole slide image management system for metabolic-associated steatohepatitis for clinical trials

Validation of a whole slide image management system for metabolic-associated steatohepatitis for clinical trials

The gold standard for enrollment and endpoint assessment in metabolic dysfunction-associated steatosis clinical trials is histologic assessment of a liver biopsy performed on glass slides. However, obtaining the evaluations from several expert pathologists on glass is challenging, as shipping the slides around the country or around the world is time-consuming and comes with the hazards of slide breakage. This study demonstrated that pathologic assessment of disease activity in steatohepatitis, performed using digital images on the AISight whole slide image management system, yields results that are comparable to those obtained using glass slides. The accuracy of scoring for steatohepatitis (nonalcoholic fatty liver disease activity score ≥4 with ≥1 for each feature and absence of atypical features suggestive of other liver disease) performed on the system was evaluated against scoring conducted on glass slides. Both methods were assessed for overall percent agreement with a consensus “ground truth” score (defined as the median score of a panel of three pathologists’ glass slides). Each case was also read by three different pathologists, once on glass and once digitally with a minimum 2-week washout period between the modalities. It was demonstrated that the average agreement across three pathologists of digital scoring with ground truth was noninferior to the average agreement of glass scoring with ground truth [noninferiority margin: −0.05; difference: −0.001; 95% CI: (−0.027, 0.026); and p < 0.0001]. For each pathologist, there was a similar average agreement of digital and glass reads with glass ground truth (pathologist A, 0.843 and 0.849; pathologist B, 0.633 and 0.605; and pathologist C, 0.755 and 0.780). Here, we demonstrate that the accuracy of digital reads for steatohepatitis using digital images is equivalent to glass reads in the context of a clinical trial for scoring using the Clinical Research Network scoring system.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Pathology Clinical Research
Journal of Pathology Clinical Research Medicine-Pathology and Forensic Medicine
CiteScore
7.40
自引率
2.40%
发文量
47
审稿时长
20 weeks
期刊介绍: The Journal of Pathology: Clinical Research and The Journal of Pathology serve as translational bridges between basic biomedical science and clinical medicine with particular emphasis on, but not restricted to, tissue based studies. The focus of The Journal of Pathology: Clinical Research is the publication of studies that illuminate the clinical relevance of research in the broad area of the study of disease. Appropriately powered and validated studies with novel diagnostic, prognostic and predictive significance, and biomarker discover and validation, will be welcomed. Studies with a predominantly mechanistic basis will be more appropriate for the companion Journal of Pathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信